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Abstract 
 
We report a new analytical method that allows the determination of the magnitude of the 
equilibrium constant of complexation, Kh, of small molecules to C60 fullerene in aqueous 
solution. The developed method is based on the up-scaled model of C60 fullerene-ligand 
complexation and contains the full set of equations needed to fit titration datasets arising from 
different experimental methods (UV-Vis spectroscopy, 1H NMR spectroscopy, diffusion ordered 
NMR spectroscopy, DLS). The up-scaled model takes into consideration the specificity of C60 
fullerene aggregation in aqueous solution and allows the highly dispersed nature of C60 fullerene 
cluster distribution to be accounted for. It also takes into consideration the complexity of 
fullerene-ligand dynamic equilibrium in solution, formed by various types of self- and hetero-
complexes. These features make the suggested method superior to standard Langmuir-type 
analysis, the approach used to date for obtaining quantitative information on ligand binding with 
different nanoparticles. 
 
Introduction 
 
C60 fullerene is now one of the most interesting and well-known allotropic forms of 
carbon particularly through its association with a large range of applications at the interface of 
biology, chemistry and physics [1-4]. A particular issue associated with C60 fullerene is its ability 
to non-covalently bind various biologically active compounds (ligands) associated with the 
extended ʌ-electron system of the C60 fullerene surface. This arises as a consequence of strong ʌ-
stacking interactions with other small molecules in aqueous solution [5]. The effect of 
complexation had mainly been investigated in terms of the formation of supramolecular C60 
fullerene-ligand ordered structures [6,7], host-guest phenomena [8,9] or C60 fullerene binding 
with micelles [10,11]. However, during the past five years the complexation of pristine C60 
fullerene with small drug molecules in aqueous solution has become a major focus of scientific 
investigation. In part, this is due to recent successes in combining co-administered C60 fullerene 
with antitumor drugs, resulting in improvement of medico-biological effects both in vivo and in 
vitro [12-15]. 
The dynamic equilibrium in solution, containing the mixture of C60 fullerenes and ligand 
molecules able to non-covalently bind with fullerene, in its simplest case may be quantified 
using two principal physico-chemical parameters, viz. the equilibrium microscopic binding 
constant, Kh, characterizing the reaction of ligand-fullerene complexation, and the equilibrium 
microscopic aggregation constant, KF, characterizing the fullerene aggregation. Although the 
dynamic equilibrium properties of C60 fullerene aqueous solutions appear to be complex and 
involve two stages of C60 fullerene cluster formation, viz. fast (diffusion-limited) and slow 
(reaction-limited) modes [16,17], it is considered that within short experiment times (i.e. the fast 
mode), the C60 fullerene aqueous solution may be considered to exist in an equilibrium state. A 
few attempts to measure Kh in non-aqueous systems are available in the literature (see [5] for a 
recent review). However, to the best of our knowledge the first experimental determination of Kh 
for various ligands in water was reported in [18,19] using light absorption spectrophotometry. 
Two major difficulties were noted, namely: 
(i) the existence of µOLJDQG-induced C60 fullerene DJJUHJDWLRQ¶UHVXOWLQJLQGUDPDWLFFKDQJHs 
to the titration curve. This effect cannot currently be accounted for resulting in the 
undesired consequence of being forced to operate with significantly reduced working 
concentration ranges; 
(ii) the very approximate evaluation of the C60 fullerene aggregation, considering just a 
limited number of small C60 fullerene clusters. 
It is also worth adding that the two difficulties mentioned do not exhaust the problems by which 
the investigator may be challenged when addressing the quantification of fullerene-ligand 
interactions. The ligand adsorption into the fullerene clusters apparently results in very complex 
molecular equilibria comprising various cluster-ligand complexes, which is difficult to evaluate 
strictly even for relatively simple ligand-ligand hetero-associations (see [20] for a review). It 
should thus be recognized that the existing approaches do not allow for the evaluation of 
fullerene-ligand interaction at wholly satisfactory level, and the method suggested in [18,19], 
although yielding the first measurement of Kh in aqueous solution, gives very approximate 
values of the equilibrium complexation constants. 
In follow-up investigations, the complexation of C60 fullerene with doxorubicin [21, 22] 
and cisplatin [23] showed that the problems encountered when working with C60 fullerene-ligand 
systems run much deeper than first realized. It was recognized that the range of classical 
physico-chemical methods typically utilized for determining binding constants for different 
molecules, such as 1H NMR spectroscopy, UV-Vis spectroscopy and isothermal titration 
calorimetry, appears to be generally useless for quantifying the C60 fullerene-ligand equilibrium. 
On the other hand, diffusion properties of the interacting molecules had been shown to act as a 
good measure of the interaction, which has provided a clue for the present study. 
In summary, it may be concluded that the existing elaboration of the methodology for 
determining C60 fullerene-ligand binding constants enables very approximate magnitudes of Kh 
to be obtained, originating from the lack of accurate complexation models or any clear 
understanding of what experimental method is best suited for studying such a system. In the 
present work we report the development of analytical approaches which enable Kh to be 
measured for any C60 fullerene-ligand complexation in aqueous solution, which accounts for the 
specificity of C60 fullerene cluster formation. 
 
Materials and Methods 
 
The highly stable purified C60 fullerene aqueous colloid solution (C60FAS, concentration 
0.15 mg/ml) was prepared according to the method reviewed in [24] and based on the technology 
of transferring C60 molecules from toluene to an aqueous phase (heavy water) with the help of 
ultrasonic treatment. Full characterization of the morphology of the resultant C60FAS is given in 
[24, 25]. 
Doxorubicin, ethidium bromide and Hoechst33256 (Sigma, Germany, Fig.1) were 
dissolved in C60FAS at concentrations of 2 mM. Titration of the prepared solution was 
accomplished from a stock solution of drug prepared at the same concentration of 2 mM in 
heavy water. This procedure was used in order to maintain the concentration of drug and vary the 
C60 fullerene concentration. 
Nuclear magnetic resonance (NMR) spectra were acquired at a magnetic field strength of 
14.1 T using a Bruker Avance III NMR spectrometer operating at a 1H resonance frequency of 
600.13 MHz and working under TopSpin version 2.1 (Bruker Biospin, Rheinstetten, Germany). 
1D 1H NMR spectra were acquired over a frequency width of 12.3 kHz (20.55 ppm) 
centered at a frequency offset equivalent to 6.175 ppm into 65536 data points during an 
acquisition time aq=2.66 s with a relaxation delay d1=2 s for each of 32 transients. All 
measurements have been performed under the fast exchange regimen on the NMR chemical shift 
timescale at T=298 K. Chemical shifts were measured relative to an internal reference standard 
of tetramethylammonium bromide (TMA) and recalculated with respect to sodium 2,2 dimethyl 
2-silapentane-5-sulphonate (DSS) DFFRUGLQJWRįDSS  įTMA + 3.178 (ppm). 
Diffusion measurements (Diffusion-Ordered NMR Spectroscopy, DOSY) were 
conducted using a bipolar gradient pulse program (Bruker pulse program ledbpgppr2s) in which 
presaturation was used to suppress residual solvent signal during the recycle delay. Typically 32 
gradient increments were used by which the gradient strength, g, was varied linearly in the range 
2  g  95% of full gradient strength (54 G/cm with a rectangular gradient) using a sine-shaped 
gradient profile. Typically the gradient pulse duration was set to 1 ms and the diffusion period to 
200 ms. Diffusion data were processed under TopSpin (version 2.1, Bruker Biospin) using the 
T1/T2 analysis module in order to fit the data to the standard expression of diffusion coefficient 
as a function of gradient strength. 
 Results and Discussion 
 
As discussed in the introductory section the principal difficulty of determining the 
magnitude of the equilibrium constant of ligand complexation with C60 is the need to take into 
consideration the specific non-linear effects in C60 fullerene-ligand complexes and strong C60 
fullerene aggregation. The latter results in highly dispersed solutions with formally indefinite 
stoichiometry m:n (m,nĺ) of the C60 fullerene-ligand complexes. Such systems are typically 
analyzed in terms of the OLJDQG¶s adsorption into C60 fullerene clusters using Langmuir and 
related analyses (see [5] for review) or using one-dimensional hetero-association models (see 
[20] for review). However, the standard adsorption models do not seem to be appropriate for 
such highly dispersed systems as C60 fullerene in aqueous solution. For this reason the 
development of a complexation model that takes into account the specificity of C60 fullerene 
aggregation is required. The most detailed analysis of complexation accounting for fractal and 
continuous C60 fullerene aggregations was accomplished in [18]. However, the severe limitation 
to the number of C60 molecules immobilized in a cluster was introduced. It does not allow large 
C60 fullerene clusters with dimensions ~100 nm and greater seen in probe microscopy images 
and dynamic light scattering spectra (DLS) to be taken into consideration [16-18,24,25]. We 
faced a virtually identical problem in [26] when trying to quantify the C60 fullerene aggregation 
in aqueous solution in terms of equilibrium aggregation constant KF. The so-called µXS-scaled 
DJJUHJDWLRQPRGHO¶ was suggested, considering C60FAS as a solution resembling that of micelles 
whose dimensions are discretely increased layer on layer with increasing solute concentration. 
The fundamental assumptions behind this model are the spherical shape of the clusters being 
formed as a result of aggregation and the non-specific nature of monomer binding. As a 
consequence, based on DLS titration data the value FK =56000 M
-1 was obtained which is in a 
good agreement with the existing theoretical estimations and the results of energetic analyses. In 
the present ZRUN WKH EDVLF LGHD EHKLQG WKH µXS-VFDOHG DJJUHJDWLRQ PRGHO¶ ZDV XVHG IRU the 
GHYHORSPHQWRIWKHµXS-scaled C60 fullerene-ligand¶FRPSOH[DWLRQPRGHO 
The general formulation of any complexation model must contain the set of equations 
enabling experimental titration data to be fitted by means of adjusting the set of model 
parameters, of which Kh is the principal search parameter (see [20,27] for review). These 
equations are (i) the set of mass balance equations, and (ii) the set of equations linking the 
experimentally observable parameter with the parameters of dynamic equilibrium in aqueous 
solution (concentrations, equilibrium complexation constants). As set out below, these equations 
will be derived for the C60 fullerene-ligand complexation, and attested to by experimental data. 
 Derivation of the mass balance equations of the up-scaled model. 
According to the up-scaled model of C60 fullerene aggregation [26] the formation of C60 
fullerene clusters is considered as simultaneous binding of R monomeric C60 molecules (termed 
µconglomerate¶WRWKHC60 fullerene core micelles containing M C60 fullerenes, with macroscopic 
binding constant, KR. Such binding results in formation of a C60 fullerene layer on the micelle 
which causes growth of C60 fullerene clusters and eventually leads to the setup of their 
equilibrium distribution. The titration of the C60 fullerene aqueous solution with the ligand is 
considered in terms of dilution of the initial C60 fullerene concentration, C0 (C0=0.14 mM), by a 
dilution factor, r. Consequently, the initial concentrations of the micelles, CM0, and 
conglomerates, CR0, are diluted by r. 
Let us consider the complexation of the ligand with C60 fullerene clusters as the binding 
of conglomerate containing D ligands with macroscopic complexation constant, KH. Hence, the 
growth of C60 fullerene clusters is determined by the attachment of C60 molecule and ligand 
layers (Fig.2). In such an approach, the searchable microscopic complexation constant may be 
defined as H
h
K
K
D
 . It follows that the full system of mass balance equations in the three-
component system µC60 fullerene clusters, CM¶ ± µOLJDQG conglomerates, CD¶ ± µC60 fullerene 
conglomerates, CR¶ can be written as: 
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where CD1 is the concentration of ligand conglomerates non-complexed with C60 fullerene 
clusters; CD0 is the total ligand concentration; CR1 and CM1 are the concentrations of non-
complexed C60 fullerene conglomerates and C60 fullerene core micelles, respectively; indexes i 
and j denote the number of C60 fullerene and ligand conglomerates, respectively, bound with the 
micelles containing M C60 molecules. 
Let us further execute the procedure of up-scaling by analogy with that performed in [26] 
by multiplying each term in the first three expressions of eqs.(1) by M. The fourth equation is 
multiplied by D. The parameters inside the brackets,  1 iR RK C , are multiplied and divided by M. 
The parameters inside the brackets,  1 jH DK C , are multiplied and divided by D. The 
corresponding transformation of eqs.(1) yields 
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where 
R
B
M
 , RR KK
M
c  , DH
M
 , 0 0M MC C Mc   , 0 0R RC C Mc   , 1 1M MC C Mc   , 1 1R RC C Mc   , 
1 1D DC C Dc   , Hh KK
D
 . 
Evaluation of the sums in eqs.(2) gives 
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Re-arranging the first and second equations in eqs.(3) with respect to 0RCc  and 1MCc  yields 
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Further solution of eqs.(4) results in the full set of monomer concentrations 
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where KF=56000 M
-1, B=0.914, C0=0.14 mM, 0MCc  0.009 mM are known from previous studies 
of C60 fullerene aggregation by means of the up-scaled model. Here, two quantities remain as 
unknowns, viz. H and Kh, which may act as adjustable parameters during the fitting of 
experimental data. As long as H was introduced in eq.(2) as a ratio of ligand number in ligand 
conglomerates, D, to fullerene number in micelles, M, this parameter may thus be associated 
with stoichiometry of the fullerene-ligand binding reaction. 
The specificity of the first expression in eqs.(5) is that it is identical to the same equation 
derived in [26] with respect to the C60 fullerene aggregation in the absence of the ligand. This is 
quite expected as in the complexation model developed, the binding of the C60 fullerene 
conglomerates (R) does not depend on the binding of the ligand conglomerates (D), i.e. the 
process of complexation does not affect the process of aggregation. 
Eqs.(5) represent the central point of the up-scaled model of C60 fullerene-ligand 
complexation. Further analysis will be devoted to obtaining equations describing the 
experimental observable for various experimental methods which can be utilized for the 
measurement of the complexation constant. 
 
Application to UV-Vis spectrophotometry. 
The observed absorption of the ligand in the visible range of the electromagnetic 
spectrum (where the overlap of the C60 fullerene and the ligand spectra is minimal) in UV-Vis 
experiments is written as 
 
  1 0m h D h DA C Cc H  H  H  (6) 
where the extinction coefficient in the C60 fullerene-ligand complex, İh, goes as the third 
adjustable parameter in the up-scaled model, i.e. [Kh, H, İh]; İm is the extinction coefficient of the 
ligand in a monomer state, commonly known from the literature or it may be measured at infinite 
ligand dilution. 
 
Application to 1H NMR experiment. 
The observed 1H NMR proton chemical shift must include the possibility of ligand self-
association at high concentrations typically used in NMR (~mM). In the most general case of 
indefinite self-association with equilibrium constant KD [28] the chemical shift measured for the 
C60 fullerene-ligand complexation is given as  
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where the chemical shift in the C60 fullerene-ligand complex, įh, goes as the third adjustable 
parameter in the up-scaled model, i.e. [Kh, H, įh]; įm is the ligand proton chemical shift in 
monomer state, commonly known from the literature or it may be measured at infinite ligand 
dilution. The first term in eq.(7) stands for the ligand self-association, and the second term 
represents the C60 fullerene-ligand binding. 
 
Application to DLS experiment. 
The light scattering intensity recorded in typical DLS experiments is recalculated into the 
hydrodynamic diameter, dz, of light scattering particles, and is determined by the square of 
molecular weight of the C60 fullerene clusters which had adsorbed the ligand. According to the 
up-scaled model these clusters comprise the core fullerene micelle, i ligand conglomerates and j 
C60 fullerene conglomerates attached to it 
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where    1 1 1i jij M F R h Df C K BC K Cc c c  is the mole fraction of the C60 fullerene-ligand clusters in 
aqueous solution; 3 31 0 1ijd d M iR jD d i B j H           is the diameter of cluster 
containing i and j layers. Here it is assumed that the hydrodynamic dimensions of the ligand and 
C60 fullerene are commensurable and equal to d1; d0 is the diameter of the core micelle equal to 
280 nm [26]. 
Taking into account the µinteraction effect¶ originating from the long-range interaction of 
C60 fullerene clusters with each other and dramatically affecting their diffusion properties (see 
[26] for more detail), the following equation should be written 
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where A' is given as the second virial coefficient characterizing the cluster-cluster long-range 
interaction [26], which may depend on the charge of the ligand. This model contains three 
adjustable parameters, i.e. [Kh, H, A']. 
 
Application to diffusion ordered NMR spectroscopy. 
A powerful alternative to DLS is diffusion ordered NMR spectroscopy (DOSY) allowing 
measurement of the translational diffusion coefficient, Dz. The up-scaled model for this type of 
experiment is similar to DLS, although the weighing of the diffusion coefficient (or the 
hydrodynamic diameter as in DLS) (
3
ij
ij
kT
D
d
 SK ) must be accomplished against the first power 
of molecular mass 
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where Ș is the solvent viscosity; k is the Boltzmann constant; T is the absolute temperature; d0 is 
the diameter of the solution component used to acquire NMR magnetization decay, which in case 
of DOSY is the characteristic ligand dimension; A' is the second virial coefficient [26]; 
   1 1 1i jij M F R h Df C K BC K Cc c c . This model formally contains three adjustable parameters, i.e. 
[Kh, H, A'] although d0 could also be taken as an adjustable quantity. 
 
Data analysis in the up-scaled model. 
The set of search binding parameters in the up-scaled model, specific to each 
experimental method and described above, can be determined by means of fitting the 
experimental titration curves given as a dependence of the experimental observable on 
concentration. The fitting may be accomplished by standard computer procedures, implemented 
in mathematical software such as Matlab, Mathematica or MathCAD, which minimize a sum of 
square deviations of the experimental and theoretically calculated [eqs.(6),(7),(9),(10)] 
observable at each concentration point (i.e. the discrepancy). Thus the discrepancy may be used 
as a measure of goodness of fit. In the present work the fitting procedure was carried out in 
Matlab. 
 
Experimental study of C60 fullerene-drug complexation. 
In order to test the up-scaled model developed in the present work we used the set of 
aromatic drug molecules representing a good model system to investigate the mechanism of C60 
fullerene-drug interaction [12-15,18-22]: doxorubicin (DOX), methylene blue (MB), proflavine 
(PF), ethidium bromide (EB) and Hoechst33258 (HT) (Fig.1). All of these drugs absorb in the 
visible range of the electromagnetic spectrum suggesting that UV-Vis spectrophotometry is 
appropriate for studying the complexation with C60 fullerene (due to minimal spectral overlap 
between the C60 and drug molecules), whereas the standard DLS method will not be appropriate 
for such analysis (due to overlap of the wavelengths of the incident laser beam and absorption 
maximum). 
The measurement of the UV-Vis experimental titration curve for DOX, PF and MB drugs 
was accomplished in [18] and outlined in Fig.3. The curves are differential (i.e. obtained as a 
difference of the absorptions in C60 fullerene-drug and ɋ60FAS) and are characterized by initial 
decrease of the optical density (due to direct drug binding to C60 molecules), replaced by further 
increase (due to additional scattering from µOLJDQG-induced C60 IXOOHUHQHDJJUHJDWLRQ¶, see Fig.4b 
in [18]). The observed changes reflect two distinct processes, of which the latter is cooperative. 
Full account of both processes within a single model is difficult. Hence, the titration range was 
reduced in [18] and the computation of the binding parameters accomplished. In the present 
work the same reduced dataset was fitted by means of the up-scaled model (eqs.(5)-(6)). The 
resultant parameters given in Table 1 evidence a good quality of fit and correlation of the 
parameters derived from the simplified model [18] and from the accurate up-scaled model 
developed here. 
Further analysis was performed with respect to 1H NMR (Fig.4) and DOSY NMR (Fig.5) 
titration data for DOX, EB and HT drugs binding with C60 fullerene. It is seen from Fig.4 that the 
changes in proton chemical shifts with concentration of C60 fullerene are relatively small 
(~«SSPDVFRPSDUHGZLWKWKHHUURURIUHSURGXFLELOLW\RIWKHNMR experiment. This 
result was also noted in [21] and explained by increased distance between the C60 fullerene and 
drug surfaces in the complex thereby minimizing the effective magnetic shielding of the drugs¶ 
protons. This indicates that the use of 1H NMR titration data for aromatic drugs binding to C60 
fullerene is inappropriate. In contrast, the DOSY curves (Fig.5) demonstrate quite strong 
concentration dependence. Moreover, the trend is different (i.e. decreasing or increasing). 
Previously the unexpected shape of the diffusion curves was noted for DOX binding with C60 
fullerene [21@DQGH[SODLQHGE\WKHµLQWHUDFWLRQHIIHFW¶GLVFXVVHGDERYHZLWKUHVSHFWWRWKH'/6
(eq.(9)) and DOSY (eq.(10)) models. The decrease/increase of the curves observed in Fig.5 
appears to be DOVR WKHFRQVHTXHQFHRI WKH LQWHUSOD\EHWZHHQ WKHµLQWHUDFWLRQHIIHFW¶ OHDGLQJ WR
increase of Dz) and the GUXJ¶VDGVRUSWLRQLQWRC60 fullerene clusters (leading to a decrease of Dz). 
Fitting of the data in Fig.5 by means of eqs.(5),(10) results in the set of binding parameters 
outlined in Table 2. The discrepancy between the theoretical model and experimental data (~10-3) 
is good enough to indicate the appropriateness of the up-scaled model (corresponding to the 
goodness of fit R2§0.95). The magnitudes of Kh weakly depend on the type of ligand evidencing 
non-specific adsorption of the drugs into the C60 fullerene clusters. This is expected because the 
drugs have similar dimensions and electrostatic charge states (bearing positive charges under 
neutral solution conditions). Similar conclusions may be drawn with respect to the magnitude of 
parameter H , which is weakly dependent upon the type of ligand and reflects the ratio of the 
number of particles in the ligand conglomerates and core micelle (eq.(2)). The ability to get 
reliable Kh values for the C60 fullerene-drug systems, demonstrated here, without any severe 
restrictions to conditions of experiment or model assumptions is the principal value of the 
developed up-scaled model, which thereby makes it superior to standard Langmuir-type 
adsorption analyses. 
A final note should be given with respect to the magnitude of the virial coefficient, A', 
characterizing the cluster-cluster long-range interaction. In [26] the value of A' for the C60 
fullerene aggregation in aqueous solution was obtained as A' §Â6 M-1, whereas in the present 
work this value for the C60 fullerene-drug complexations became negative (see Table 2). This 
result may be explained by intrinsic repulsion of negatively charged C60 fullerene clusters in 
aqueous solution (giving a positive A' value in the case of aggregation without the ligand) and 
slight attraction of the clusters containing positively charged drug molecules (giving a negative 
A' value in the case of drugs complexing with C60 fullerene clusters). These conclusions are 
VXSSRUWHG E\ WKH DYDLODEOH ȟ-potential measurements for C60FAS without the drug and for the 
mixture of DOX with C60FAS [21], i.e. the C60 fullerene clusters are characterized by deep 
negative values RI ȟ-potential, whereas the addition of positively-charged DOX to C60FAS 
causes a significant shift of ȟ-potential to small positive values. However, the A' parameter 
should not totally be related to the electrostatic charge of the C60 fullerene-drug clusters. Large 
particles in aqueous solution, even being electrically neutral, also interact via long-range van der 
Waals interactions, formed by summation of the standard 1/r6 attractive London potential [29]. It 
follows that the up-scaled model developed in the present work, in addition to measurement of 
Kh, may also provide unique information on the long-range cluster-cluster interaction. 
 
Conclusions 
 
In the present work we report a new analytical method enabling the determination of the 
magnitude of the equilibrium constant of complexation, Kh, of small molecules binding to C60 
fullerene in aqueous solution. The developed method is based on the up-scaled model of C60 
fullerene-ligand complexation and contains the full set of equations needed to fit titration dataset 
data for different experimental methods (UV-Vis spectroscopy, 1H NMR spectroscopy, diffusion 
ordered NMR spectroscopy, DLS). The up-scaled model takes into consideration the specificity 
of C60 fullerene aggregation in aqueous solution allowing the highly dispersed nature of C60 
fullerene cluster distribution to be accounted for. This feature makes the suggested method 
superior to standard Langmuir-type analysis, a method used to date for obtaining quantitative 
information on ligand binding with different nanoparticles. 
It is suggested that measurement of the translational diffusion coefficient by means of 
diffusion-ordered NMR spectroscopy is probably the most suited method for measuring Kh for 
C60 fullerene-ligand systems. Many common methods such as 
1H NMR, isothermal titration 
calorimetry, UV-Vis and DLS do not sense interaction or involve additional severe restrictions to 
the analytical procedure, thus lowering the reliability of analysis. In contrast, the DOSY method 
senses the translational diffusion coefficient of the drug, which is determined by interplay of two 
major processes, viz. the ligand adsorption into C60 fullerene clusters and the cluster-cluster 
long-range interaction. Both of these features have been incorporated into the up-scaled model. 
In addition, from the value of the second virial coefficient, A', the method provides uniquely 
quantitative information on the long-range cluster-cluster interaction, exerting correlation with 
the standard ȟ-potential of nanoparticles measured in aqueous solution. 
In conclusion it should be noted that one of the principal difficulties in quantifying the 
fullerene-ligand binding process is accounting for the non-linear cooperative processes (such as 
the ligand-induced fullerene aggregation), which were not considered in the present work, but is 
thought to be possible within the up-scaled model, and will be a matter for further studies. 
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Table 1. The calculated parameters of the C60 fullerene-drug complexation derived from fitting of 
the reduced UV-Vis titration data 
 
Adjustable 
parameter 
C60-DOX C60-MB C60-PF 
H 3 3 2 
Kh, M
-1 21000 (46000) 8300 (7300) 9500 (12800) 
discrepancy 8.2Â10-3 6.8Â10-3 9.0Â10-3 
Note: the numbers in brackets represent the binding parameters computed by simplified 
complexation model in [18] 
 
 
Table 2. The calculated parameters of the C60 fullerene-drug complexation derived from fitting of 
the DOSY NMR titration data by means of the up-scaled model 
 
Adjustable 
parameter 
C60-DOX C60-EB C60-HT 
H 2.75 2.90 1.65 
Kh, M
-1 500 516 490 
A', M-1 -16000 -16000 -14500 
discrepancy 6.7Â10-3 2.8Â10-3 1.1Â10-3 
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Figure 1 Structures of the studied drug molecules 
Doxorubicin 
Methylene Blue 
Proflavine 
Ethidium bromide 
Hoechst33258 
  
 
 
Figure 2 Schematic representation of the complexation process in the up-scaled model 
  
 
Figure 3 Experimental titration curves (reduced dataset, see discussion in the text; reprinted from 
[18] with permission) 
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Fig.4 Experimental dependencies of 1H NMR chemical shifts of the drug molecules on fullerene 
C60 concentration: (a) Doxorubicin, (b) Ethidium bromide, (c) Hoechst 33258 
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Fig.5 Experimental dependencies of translational diffusion coefficient of the drug molecules on 
fullerene C60 concentration 
 
 
